In the News

Tight BP control associated with improved outcomes in diabetics

Hypertension treatment reduces mortality and cardiovascular events in patients with type 2 diabetes, but it is underused, according to 2 recent studies.

All-cause mortality risk with type 1 diabetes may be greater in women vs. men

Women with type 1 diabetes may have a higher all-cause mortality risk than men with the condition, as well as higher risk for fatal and nonfatal vascular events, according to a recent study.

Diabetes spending has increased, mostly due to prescription costs

Managing diabetes has become more expensive in the past 20 years, mostly due to more spending on drugs, a study found, while a second paper suggested that older patients are more likely to be using medications to control their condition.

MKSAP question: Hypertension treatment in type 2 diabetes

This month's quiz asks readers to evaluate a 60-year-old man, diagnosed with type 2 diabetes mellitus during a health insurance evaluation 6 months ago, as a new patient.

Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia

Combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin was associated with lower HbA1c values, less weight gain, and similar hypoglycemia rates compared to other type 2 diabetes treatment regimens, according to a meta-analysis.

Improved mortality rates in diabetic ICU patients appear to be independent of glucose control, study finds

Improved mortality rates in diabetic ICU patients over the past decade appear to be independent of glucose control, according to a new study.

Glucose monitoring app, weight-loss device, medications approved

The FDA approved an app for continuous glucose monitoring, a weight-loss device, a combination diabetes pill, and a new indication for an eye medication in the past month.